InsiderGauge
Checking updates…
Dashboard

MBXMBX Biosciences, Inc.

Market cap
$2.34B
as of 2026-10-23
Latest close
$48.50
as of 2026-10-23
Sector
Healthcare
as of 2026-10-24
Industry
Biotechnology
as of 2026-10-24

Cluster

No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).

Form 4 historysince 2024-09-13

Dashed line = amended filing (Form 4/A)

InsiderTradedFiledTypeSharesPriceValueOwned after10b5-1 planFiling
Radovich PeterOct 20Oct 22A · derivative18,200$53.50$973,70018,200NoForm 4
Azoulay SalomonChief Medical OfficerAug 4Aug 5S370$65.77Sale −$24,33514,399NoForm 4
Hoerter Steven L.President and CEOAug 3Aug 4A71,000$0.00$082,938NoForm 4
Hoerter Steven L.President and CEOAug 3Aug 4A · derivative331,000$64.41$21,319,710331,000NoForm 4
Smither John WChief Financial OfficerAug 3Aug 4A28,000$0.00$028,000NoForm 4
Smither John WChief Financial OfficerAug 3Aug 4A · derivative130,000$64.41$8,373,300130,000NoForm 4
Aynechi TibaJun 4Jun 5A · derivative12,500$30.91$386,37512,500NoForm 4
Ryder StevenJun 4Jun 5A · derivative12,500$30.91$386,37512,500NoForm 4
Hoerter Steven L.Jun 4Jun 5A · derivative12,500$30.91$386,37512,500NoForm 4
Stelzer LaurieJun 4Jun 5A · derivative12,500$30.91$386,37512,500NoForm 4
Heron Patrick JJun 4Jun 5A · derivative12,500$30.91$386,37512,500NoForm 4
Pescovitz Ora H.Jun 4Jun 5A · derivative12,500$30.91$386,37512,500NoForm 4
Mathers Edward TJun 4Jun 5A · derivative12,500$30.91$386,37512,500NoForm 4
Azoulay SalomonChief Medical OfficerMay 8May 11M55,000$10.46$575,30069,769YesForm 4
Azoulay SalomonChief Medical OfficerMay 8May 11S55,000$38.38Sale −$2,110,90014,769YesForm 4
Azoulay SalomonChief Medical OfficerMay 8May 11M15,003$16.00$240,04829,772YesForm 4
Azoulay SalomonChief Medical OfficerMay 8May 11S15,003$38.30Sale −$574,61514,769YesForm 4
Azoulay SalomonChief Medical OfficerMay 8May 11M · derivative55,000$10.46$575,300194,540YesForm 4
Azoulay SalomonChief Medical OfficerMay 8May 11M · derivative15,003$16.00$240,04830,008YesForm 4
Hawryluk P. KentPresident & CEOMay 6May 8S607$29.54Sale −$17,931727,667NoForm 4
Azoulay SalomonChief Medical OfficerMay 6May 8S231$29.54Sale −$6,82414,769NoForm 4
Hoerter Steven L.May 1May 4A11,938$0.00$011,938NoForm 4
Hoerter Steven L.May 1May 4A · derivative74,249$29.78$2,211,13574,249NoForm 4
Hoerter Steven L.Nov 22, 2025Apr 224/AA · derivative0$27.08$0not reportedNoForm 4/A
Hoerter Steven L.Nov 6, 2025Apr 224/AA · derivative33,751$24.74$835,00033,751NoForm 4/A
Hawryluk P. KentPresident & CEOMar 13Mar 16P18,500$28.41Purchase +$525,585486,777NoForm 4
Hawryluk P. KentPresident & CEOFeb 26Feb 27M28,768$16.00$460,288728,274NoForm 4
Hawryluk P. KentPresident & CEOFeb 26Feb 27M · derivative28,768$16.00$460,28891,668NoForm 4
Hawryluk P. KentPresident & CEOFeb 2Feb 3A35,250$0.00$0699,506NoForm 4
Hawryluk P. KentPresident & CEOFeb 2Feb 3A · derivative164,500$39.07$6,427,015164,500NoForm 4
Bartram RichardChief Financial OfficerFeb 2Feb 3A15,000$0.00$015,000NoForm 4
Bartram RichardChief Financial OfficerFeb 2Feb 3A · derivative70,000$39.07$2,734,90070,000NoForm 4
Azoulay SalomonChief Medical OfficerFeb 2Feb 3A15,000$0.00$015,000NoForm 4
Azoulay SalomonChief Medical OfficerFeb 2Feb 3A · derivative70,000$39.07$2,734,90070,000NoForm 4
Stelzer LaurieJan 20Jan 22A · derivative32,000$43.14$1,380,48032,000NoForm 4
Hawryluk P. KentPresident & CEOOct 24, 2025Oct 28, 2025M182,859$3.25$594,292664,256NoForm 4
Hawryluk P. KentPresident & CEOOct 24, 2025Oct 28, 2025M · derivative182,859$3.25$594,292129,708NoForm 4
Hawryluk P. KentPresident & CEOOct 20, 2025Oct 21, 2025P20,000$13.64Purchase +$272,800468,277NoForm 4
Hoerter Steven L.Oct 17, 2025Oct 20, 2025P20,000$13.25Purchase +$265,00020,000NoForm 4
Fhmls X, L.P.Sep 26, 2025Sep 30, 2025P666,666$18.00Purchase +$11,999,9885,219,440NoForm 4
Pescovitz Ora H.Jun 5, 2025Jun 6, 2025A · derivative16,000$11.86$189,76016,000NoForm 4
Heron Patrick JJun 5, 2025Jun 6, 2025A · derivative16,000$11.86$189,76016,000NoForm 4
Ryder StevenJun 5, 2025Jun 6, 2025A · derivative16,000$11.86$189,76016,000NoForm 4
Cornelius James MJun 5, 2025Jun 6, 2025A · derivative16,000$11.86$189,76016,000NoForm 4
Aynechi TibaJun 5, 2025Jun 6, 2025A · derivative16,000$11.86$189,76016,000NoForm 4
Hoerter Steven L.Jun 5, 2025Jun 6, 2025A · derivative16,000$11.86$189,76016,000NoForm 4
Mathers Edward TJun 5, 2025Jun 6, 2025A · derivative16,000$11.86$189,76016,000NoForm 4
Pescovitz Ora H.Apr 8, 2025Apr 10, 2025P7,693$5.89Purchase +$45,31224,329NoForm 4
Hoerter Steven L.Apr 7, 2025Apr 9, 2025A · derivative32,000$6.00$192,00032,000NoForm 4
OrbiMed Genesis GP LLCFeb 18, 2025Feb 19, 2025P49,070$10.84Purchase +$531,9193,255,000NoForm 4
OrbiMed Genesis GP LLCFeb 18, 2025Feb 19, 2025P94,100$10.84Purchase +$1,020,044747,887NoForm 4
Gordon Carl LFeb 18, 2025Feb 19, 2025P49,070$10.84Purchase +$531,9193,255,000NoForm 4
Gordon Carl LFeb 18, 2025Feb 19, 2025P94,100$10.84Purchase +$1,020,044747,887NoForm 4
OrbiMed Genesis GP LLCFeb 14, 2025Feb 19, 2025P17,962$9.90Purchase +$177,8243,176,390NoForm 4
OrbiMed Genesis GP LLCFeb 14, 2025Feb 19, 2025P29,540$9.85Purchase +$290,9693,205,930NoForm 4
Gordon Carl LFeb 14, 2025Feb 19, 2025P17,962$9.90Purchase +$177,8243,176,390NoForm 4
Gordon Carl LFeb 14, 2025Feb 19, 2025P29,540$9.85Purchase +$290,9693,205,930NoForm 4
Hawryluk P. KentPresident & CEOFeb 4, 2025Feb 5, 2025P50,000$10.69Purchase +$534,500448,277NoForm 4
Hawryluk P. KentPresident & CEOFeb 3, 2025Feb 5, 2025A · derivative243,000$10.49$2,549,070243,000NoForm 4
Bartram RichardChief Financial OfficerFeb 3, 2025Feb 5, 2025A · derivative95,000$10.49$996,55095,000NoForm 4
Azoulay SalomonChief Medical OfficerFeb 3, 2025Feb 5, 2025A · derivative90,000$10.49$944,10090,000NoForm 4
Wellington Biomedical Innovation Master Investors (Cayman) II L.P.Sep 16, 2024Sep 17, 2024C1,386,335not reportednot reported1,386,335NoForm 4
Wellington Biomedical Innovation Master Investors (Cayman) II L.P.Sep 16, 2024Sep 17, 2024C403,787not reportednot reported1,790,122NoForm 4
Wellington Biomedical Innovation Master Investors (Cayman) II L.P.Sep 16, 2024Sep 17, 2024C · derivative16,666,666$0.00$0not reportedNoForm 4
Wellington Biomedical Innovation Master Investors (Cayman) II L.P.Sep 16, 2024Sep 17, 2024C · derivative4,854,368$0.00$0not reportedNoForm 4
Gordon Carl LSep 16, 2024Sep 17, 2024C2,658,428not reportednot reported2,658,428NoForm 4
Gordon Carl LSep 16, 2024Sep 17, 2024C403,787not reportednot reported403,787NoForm 4
Gordon Carl LSep 16, 2024Sep 17, 2024P500,000$16.00Purchase +$8,000,0003,158,428NoForm 4
Gordon Carl LSep 16, 2024Sep 17, 2024P250,000$16.00Purchase +$4,000,000653,787NoForm 4
Gordon Carl LSep 16, 2024Sep 17, 2024C · derivative12,372,634not reportednot reportednot reportedNoForm 4
Gordon Carl LSep 16, 2024Sep 17, 2024C · derivative19,587,284not reportednot reportednot reportedNoForm 4
Gordon Carl LSep 16, 2024Sep 17, 2024C · derivative4,854,368not reportednot reportednot reportedNoForm 4
Aynechi TibaSep 16, 2024Sep 17, 2024C1,386,335not reportednot reported1,386,335NoForm 4
Aynechi TibaSep 16, 2024Sep 17, 2024P750,000$16.00Purchase +$12,000,0002,136,335NoForm 4
Aynechi TibaSep 16, 2024Sep 17, 2024C · derivative16,666,666not reportednot reportednot reportedNoForm 4
Hawryluk P. KentPresident & CEOSep 16, 2024Sep 17, 2024C283,846not reportednot reported481,397NoForm 4
Hawryluk P. KentPresident & CEOSep 16, 2024Sep 17, 2024C115,914not reportednot reported398,277NoForm 4
Hawryluk P. KentPresident & CEOSep 16, 2024Sep 17, 2024C · derivative2,015,681not reportednot reportednot reportedNoForm 4
Hawryluk P. KentPresident & CEOSep 16, 2024Sep 17, 2024C · derivative345,705not reportednot reportednot reportedNoForm 4
Hawryluk P. KentPresident & CEOSep 16, 2024Sep 17, 2024C · derivative1,396,762not reportednot reportednot reportedNoForm 4
Hawryluk P. KentPresident & CEOSep 16, 2024Sep 17, 2024C · derivative76,969not reportednot reportednot reportedNoForm 4
Hawryluk P. KentPresident & CEOSep 16, 2024Sep 17, 2024C · derivative970,873not reportednot reportednot reportedNoForm 4
Heron Patrick JSep 16, 2024Sep 17, 2024C3,927,774not reportednot reported3,927,774NoForm 4
Heron Patrick JSep 16, 2024Sep 17, 2024P625,000$16.00Purchase +$10,000,0004,552,774NoForm 4
Heron Patrick JSep 16, 2024Sep 17, 2024C · derivative18,922,852not reportednot reportednot reportedNoForm 4
Heron Patrick JSep 16, 2024Sep 17, 2024C · derivative28,297,265not reportednot reportednot reportedNoForm 4
Cornelius James MSep 16, 2024Sep 17, 2024C102,082not reportednot reported102,082NoForm 4
Cornelius James MSep 16, 2024Sep 17, 2024C · derivative994,069not reportednot reportednot reportedNoForm 4
Cornelius James MSep 16, 2024Sep 17, 2024C · derivative233,192not reportednot reportednot reportedNoForm 4
Fhmls X, L.P.Sep 16, 2024Sep 17, 2024C3,927,774not reportednot reported3,927,774NoForm 4
Fhmls X, L.P.Sep 16, 2024Sep 17, 2024P625,000$16.00Purchase +$10,000,0004,552,774NoForm 4
Fhmls X, L.P.Sep 16, 2024Sep 17, 2024C · derivative18,922,852not reportednot reportednot reportedNoForm 4
Fhmls X, L.P.Sep 16, 2024Sep 17, 2024C · derivative28,297,265not reportednot reportednot reportedNoForm 4
NEA Partners 17, L.P.Sep 16, 2024Sep 17, 2024C1,023,103not reportednot reported1,023,103NoForm 4
NEA Partners 17, L.P.Sep 16, 2024Sep 17, 2024C2,091,383not reportednot reported3,114,486NoForm 4
NEA Partners 17, L.P.Sep 16, 2024Sep 17, 2024P500,000$16.00Purchase +$8,000,0003,614,486NoForm 4
NEA Partners 17, L.P.Sep 16, 2024Sep 17, 2024C · derivative12,299,854not reportednot reportednot reportedNoForm 4
NEA Partners 17, L.P.Sep 16, 2024Sep 17, 2024C · derivative25,142,840not reportednot reportednot reportedNoForm 4
Orbimed Advisors LLCSep 16, 2024Sep 17, 2024C2,658,428not reportednot reported2,658,428NoForm 4
Orbimed Advisors LLCSep 16, 2024Sep 17, 2024C403,787not reportednot reported403,787NoForm 4
Orbimed Advisors LLCSep 16, 2024Sep 17, 2024P500,000$16.00Purchase +$8,000,0003,158,428NoForm 4
Orbimed Advisors LLCSep 16, 2024Sep 17, 2024P250,000$16.00Purchase +$4,000,000653,787NoForm 4
Orbimed Advisors LLCSep 16, 2024Sep 17, 2024C · derivative12,372,634not reportednot reportednot reportedNoForm 4
Orbimed Advisors LLCSep 16, 2024Sep 17, 2024C · derivative19,587,284not reportednot reportednot reportedNoForm 4
Orbimed Advisors LLCSep 16, 2024Sep 17, 2024C · derivative4,854,368not reportednot reportednot reportedNoForm 4
Sandell Scott DSep 16, 2024Sep 17, 2024C1,023,103not reportednot reported1,023,103NoForm 4
Sandell Scott DSep 16, 2024Sep 17, 2024C2,091,383not reportednot reported3,114,486NoForm 4
Sandell Scott DSep 16, 2024Sep 17, 2024P500,000$16.00Purchase +$8,000,0003,614,486NoForm 4
Sandell Scott DSep 16, 2024Sep 17, 2024C · derivative12,299,854not reportednot reportednot reportedNoForm 4
Sandell Scott DSep 16, 2024Sep 17, 2024C · derivative25,142,840not reportednot reportednot reportedNoForm 4
Yang RickSep 16, 2024Sep 17, 2024C1,023,103not reportednot reported1,023,103NoForm 4
Yang RickSep 16, 2024Sep 17, 2024C2,091,383not reportednot reported3,114,486NoForm 4
Yang RickSep 16, 2024Sep 17, 2024P500,000$16.00Purchase +$8,000,0003,614,486NoForm 4
Yang RickSep 16, 2024Sep 17, 2024C · derivative12,299,854not reportednot reportednot reportedNoForm 4
Yang RickSep 16, 2024Sep 17, 2024C · derivative25,142,840not reportednot reportednot reportedNoForm 4
Walker Paul EdwardSep 16, 2024Sep 17, 2024C1,023,103not reportednot reported1,023,103NoForm 4
Walker Paul EdwardSep 16, 2024Sep 17, 2024C2,091,383not reportednot reported3,114,486NoForm 4
Walker Paul EdwardSep 16, 2024Sep 17, 2024P500,000$16.00Purchase +$8,000,0003,614,486NoForm 4
Walker Paul EdwardSep 16, 2024Sep 17, 2024C · derivative12,299,854not reportednot reportednot reportedNoForm 4
Walker Paul EdwardSep 16, 2024Sep 17, 2024C · derivative25,142,840not reportednot reportednot reportedNoForm 4
Makhzoumi MohamadSep 16, 2024Sep 17, 2024C1,023,103not reportednot reported1,023,103NoForm 4
Makhzoumi MohamadSep 16, 2024Sep 17, 2024C2,091,383not reportednot reported3,114,486NoForm 4
Makhzoumi MohamadSep 16, 2024Sep 17, 2024P500,000$16.00Purchase +$8,000,0003,614,486NoForm 4
Makhzoumi MohamadSep 16, 2024Sep 17, 2024C · derivative12,299,854not reportednot reportednot reportedNoForm 4
Makhzoumi MohamadSep 16, 2024Sep 17, 2024C · derivative25,142,840not reportednot reportednot reportedNoForm 4
Florence Anthony A. Jr.Sep 16, 2024Sep 17, 2024C1,023,103not reportednot reported1,023,103NoForm 4
Florence Anthony A. Jr.Sep 16, 2024Sep 17, 2024C2,091,383not reportednot reported3,114,486NoForm 4
Florence Anthony A. Jr.Sep 16, 2024Sep 17, 2024P500,000$16.00Purchase +$8,000,0003,614,486NoForm 4
Florence Anthony A. Jr.Sep 16, 2024Sep 17, 2024C · derivative12,299,854not reportednot reportednot reportedNoForm 4
Florence Anthony A. Jr.Sep 16, 2024Sep 17, 2024C · derivative25,142,840not reportednot reportednot reportedNoForm 4
Chang CarmenSep 16, 2024Sep 17, 2024C1,023,103not reportednot reported1,023,103NoForm 4
Chang CarmenSep 16, 2024Sep 17, 2024C2,091,383not reportednot reported3,114,486NoForm 4
Chang CarmenSep 16, 2024Sep 17, 2024P500,000$16.00Purchase +$8,000,0003,614,486NoForm 4
Chang CarmenSep 16, 2024Sep 17, 2024C · derivative12,299,854not reportednot reportednot reportedNoForm 4
Chang CarmenSep 16, 2024Sep 17, 2024C · derivative25,142,840not reportednot reportednot reportedNoForm 4
Behbahani AliSep 16, 2024Sep 17, 2024C1,023,103not reportednot reported1,023,103NoForm 4
Behbahani AliSep 16, 2024Sep 17, 2024C2,091,383not reportednot reported3,114,486NoForm 4
Behbahani AliSep 16, 2024Sep 17, 2024P500,000$16.00Purchase +$8,000,0003,614,486NoForm 4
Behbahani AliSep 16, 2024Sep 17, 2024C · derivative12,299,854not reportednot reportednot reportedNoForm 4
Behbahani AliSep 16, 2024Sep 17, 2024C · derivative25,142,840not reportednot reportednot reportedNoForm 4
Baskett ForestSep 16, 2024Sep 17, 2024C1,023,103not reportednot reported1,023,103NoForm 4
Baskett ForestSep 16, 2024Sep 17, 2024C2,091,383not reportednot reported3,114,486NoForm 4
Baskett ForestSep 16, 2024Sep 17, 2024P500,000$16.00Purchase +$8,000,0003,614,486NoForm 4
Baskett ForestSep 16, 2024Sep 17, 2024C · derivative12,299,854not reportednot reportednot reportedNoForm 4
Baskett ForestSep 16, 2024Sep 17, 2024C · derivative25,142,840not reportednot reportednot reportedNoForm 4
Mathers Edward TSep 16, 2024Sep 17, 2024C1,023,103not reportednot reported1,023,103NoForm 4
Mathers Edward TSep 16, 2024Sep 17, 2024C2,091,383not reportednot reported3,114,486NoForm 4
Mathers Edward TSep 16, 2024Sep 17, 2024P500,000$16.00Purchase +$8,000,0003,614,486NoForm 4
Mathers Edward TSep 16, 2024Sep 17, 2024C · derivative12,299,854not reportednot reportednot reportedNoForm 4
Mathers Edward TSep 16, 2024Sep 17, 2024C · derivative25,142,840not reportednot reportednot reportedNoForm 4
Pescovitz Ora H.Sep 12, 2024Sep 13, 2024A · derivative15,963$16.00$255,40815,963NoForm 4
Cornelius James MSep 12, 2024Sep 13, 2024A · derivative15,963$16.00$255,40815,963NoForm 4
Heron Patrick JSep 12, 2024Sep 13, 2024A · derivative15,963$16.00$255,40815,963NoForm 4
Aynechi TibaSep 12, 2024Sep 13, 2024A · derivative15,963$16.00$255,40815,963NoForm 4
Hawryluk P. KentPresident & CEOSep 12, 2024Sep 13, 2024A · derivative120,436$16.00$1,926,976120,436NoForm 4
Mathers Edward TSep 12, 2024Sep 13, 2024A · derivative15,963$16.00$255,40815,963NoForm 4
Azoulay SalomonChief Medical OfficerSep 12, 2024Sep 13, 2024A · derivative45,011$16.00$720,17645,011NoForm 4
Bartram RichardChief Financial OfficerSep 12, 2024Sep 13, 2024A · derivative42,578$16.00$681,24842,578NoForm 4
Ryder StevenSep 12, 2024Sep 13, 2024A · derivative15,963$16.00$255,40815,963NoForm 4
Gordon Carl LSep 12, 2024Sep 13, 2024A · derivative15,963$16.00$255,40815,963NoForm 4